Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Rankning i aktier #40225
Fusion Antibodies plc operates as a contract research organization (CRO),... Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.
Aktiekurs
$0.1559364
Senast synkroniserad: 2026-09-18
Marknadsvärde
$195.17K
Förändring (1 dag)
6.60%
Förändring (1 år)
-30.91%
Land
GB
Handel Fusion Antibodies plc (FAB)

Kategori

Historik för aktiesplit för Fusion Antibodies plc (FAB)
Aktien Fusion Antibodies plc (symbol: FAB) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Sep 20, 2026.
En FAB-aktie köpt före Sep 20, 2026 motsvarar nu 0 FAB-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH